Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?

Quality of Life Research

Volumn 23, Issue 2, 2014, Pages 689-698

  Tan, Elise Chia Hui ^a   Pwu, Raoh Fang ^b,c   Chen, Duan Rung ^a   Yang, Ming Chin ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Center for Drug Evaluation   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cost effectiveness; Diabetes mellitus; Incremental cost effectiveness ratio; Pay for performance

Indexed keywords

INSULIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; COST BENEFIT ANALYSIS; DIABETES MELLITUS; ECONOMICS; FEMALE; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REIMBURSEMENT; RETROSPECTIVE STUDY; TAIWAN; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; COST-BENEFIT ANALYSIS; DIABETES MELLITUS; FEMALE; HEALTH SURVEYS; HUMANS; INSULIN; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; REIMBURSEMENT, INCENTIVE; RETROSPECTIVE STUDIES; TAIWAN; YOUNG ADULT;

EID: 84900382051     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-013-0502-x     Document Type: Article

References (47)

1. Institute of Medicine. (2001). Crossing the Quality Chasm: A new Health System for the 21st Century. Washington, DC: National Academies Press.
2. Chen, J. Y.; Tian, H.; Taira Juarez, D.; Hodges, K. A.; Brand, J. C.; Chung, R. S.; et al. (2010). The effect of a PPO pay-for-performance program on patients with diabetes. American Journal of Managed Care, 16(1), e11-e19.
3. Lee, T. T.; Cheng, S. H.; Chen, C. C.; Lai, M. S. (2010). A pay-for-performance program for diabetes care in Taiwan: A preliminary assessment. American Journal of Managed Care, 16(1), 65-69.
4. Levin-Scherz, J.; DeVita, N.; Timbie, J. (2006). Impact of pay-for-performance contracts and network registry on diabetes and asthma HEDIS measures in an integrated delivery network. Medical Care Research and Review, 63(1 Suppl), 14S-28S.
5. Tahrani, A. A.; McCarthy, M.; Godson, J.; Taylor, S.; Slater, H.; Capps, N.; et al. (2007). Diabetes care and the new GMS contract: The evidence for a whole county. British Journal of General Practice, 57(539), 483-485.
6. Campbell, S. M.; Reeves, D.; Kontopantelis, E.; Sibbald, B.; Roland, M. (2009). Effects of pay for performance on the quality of primary care in England. New England Journal of Medicine, 361(4), 368-378.
7. Vaghela, P.; Ashworth, M.; Schofield, P.; Gulliford, M. C. (2009). Population intermediate outcomes of diabetes under pay-for-performance incentives in England from 2004 to 2008. Diabetes Care, 32(3), 427-429.
8. Hillman, A. L.; Ripley, K.; Goldfarb, N.; Nuamah, I.; Weiner, J.; Lusk, E. (1998). Physician financial incentives and feedback: Failure to increase cancer screening in Medicaid managed care. American Journal of Public Health, 88(11), 1699-1701.
9. Glickman, S. W.; Ou, F. S.; DeLong, E. R.; Roe, M. T.; Lytle, B. L.; Mulgund, J.; et al. (2007). Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA, 297(21), 2373-2380.
10. Fagan, P. J.; Schuster, A. B.; Boyd, C.; Marsteller, J. A.; Griswold, M.; Murphy, S. M. E.; et al. (2010). Chronic care improvement in primary care: Evaluation of an integrated pay-for-performance and practice-based care coordination program among elderly patients with diabetes. Health Services Research, 45(6), 1763-1782.
11. Department of Health, E. Y.; R.O.C. (Taiwan) (2010). 2009 Statistic of Cause of Death. Taipei City.
12. Bureau of National Health Insurance, D. o. H.; Executive Yuan, R.O.C. (Taiwan). (2010). The 2009 National Health Insurance Annual Health Statistical Report. Taipei City.
13. Chiou, S. T.; Lin, H. D.; Yu, N. C.; Hseuh, H. K.; Lin, L. H.; Lin, L. T.; et al. (2001). An initial assessment of the feasibility and effectiveness of implementing diabetes shared care system in Taiwan - some experiences from I-Lan County. Diabetes Research and Clinical Practice, 54(Suppl 1), S67-S73.
14. Bureau of National Health Insurance. National Health Insurance Pay-for-Performance Program for Diabetes [in Chinese]. Retrieved June 20, 2011, from http://www.nhi.gov.tw/webdata/webdata.aspx?menu=18&menu-id= 703&webdata-id=3862&WD-ID=941.
15. Lee, T-. T.; Cheng, S.-H.; Chen, C-. C.; Lai, M.-S. (2010). A pay-for-performance program for diabetes care in Taiwan: A preliminary assessment. American Journal of Managed Care, 16(1), 65-69.
16. Cheng, S. H.; Lee, T. T.; Chen, C. C. (2012). A longitudinal examination of a pay-for-performance program for diabetes care evidence from a natural experiment. Medical Care, 50(2), 109-116.
17. Chen, P. C.; Lee, Y. C.; Kuo, R. N. (2012). Differences in patient reports on the quality of care in a diabetes pay-for-performance program between 1 year enrolled and newly enrolled patients. International Journal for Quality in Health Care, 24(2), 189-196.
18. Gold, M. R.; Sigegl, J. E.; Russell, L. B.; Weinstein, M. C. (1996). Cost Effectiveness in Health and Medicine. New York: Oxford University Press.
19. Krummenauer, F.; Wolf, C.; Gunther, K. P.; Kirschner, S. (2009). Clinical benefit and cost effectiveness of total knee arthroplasty in the older patient. European Journal of Medical Research, 14(2), 76-84.
20. Pollock, R. F.; Muduma, G.; Valentine, W. J. (2013). Evaluating the cost-effectiveness of laparoscopic adjustable gastric banding versus standard medical management in obese patients with type 2 diabetes in the UK. Diabetes, Obesity and Metabolism, 15(2), 121-129.
21. Weng, W. S.; Liu, C. Y.; Chen, Y. J.; Chang, H. Y.; Liang, K. Y.; Chuang, Y. L. (2006). The sampling design for the 2005 National Health Interview Survey in Taiwan. NHIS Research Brief, 2, 1-16.
22. Li, C. L.; Chang, H. Y.; Wang, H. H.; Bai, Y. B. (2011). Diabetes, functional ability, and self-rated health independently predict hospital admission within one year among older adults: A population based cohort study. Archives of Gerontology and Geriatrics, 52(2), 147-152.
23. National Health Research Institute. National Health Interview Survey. Retrieved June 16, 2011, from http://nhis.nhri.org.tw/2005nhis.html.
24. Chang, W. C.; Lan, T. H.; Ho, W. C.; Lan, T. Y. (2010). Factors affecting the use of health examinations by the elderly in Taiwan. Archives of Gerontology and Geriatrics, 50(Suppl 1), S11-S16.
25. Wu, M. S.; Lan, T. H.; Chen, C. M.; Chiu, H. C.; Lan, T. Y. (2011). Socio-demographic and health-related factors associated with cognitive impairment in the elderly in Taiwan. BMC Public Health, 11, 22.
26. Wu, W. C.; Chang, H. Y.; Kuo, K. N.; Chen, C. Y.; Tu, Y. C.; Yang, Y. H. (2011). Psychosocial problems in children with allergic diseases: A population study in Taiwan. Child: Care, Health and Development, 37, 662.
27. Lin, C. C.; Lai, M. S.; Syu, C. Y.; Chang, S. C.; Tseng, F. Y. (2005). Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. Journal of the Formosan Medical Association, 104(3), 157-163.
28. Miller, C. K.; Kristeller, J. L.; Headings, A.; Nagaraja, H.; Miser, W. F. (2012). Comparative effectiveness of a mindful eating intervention to a diabetes self-management intervention among adults with type 2 diabetes: A pilot study. Journal of the Academy of Nutrition and Dietetics, 112(11), 1835-1842.
29. Rosenbaum, P. R.; Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41-55.
30. D'Agostino, R. B. (1998). Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine, 17(19), 2265-2281.
31. Knox, S. (2013). Sample size calculation in economic evaluation. Australia: The Centre for Health Economic Research and Evaluation (CHERE).
32. Glick, H. A. (2011). Sample size and power for cost-effectiveness analysis (Part 1). Pharmacoeconomics, 29(3), 189-198.
33. Glick, H. A. (2011). Sample size and power for cost-effectiveness analysis (Part 2) the effect of maximum willingness to pay. Pharmacoeconomics, 29(4), 287-296.
34. Brazier, J.; Roberts, J.; Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271-292.
35. McCabe, C.; Brazier, J.; Gilks, P.; Tsuchiya, A.; Roberts, J.; O'Hagan, A.; et al. (2006). Using rank data to estimate health state utility models. Journal of Health Economics, 25(3), 418-431.
36. Kharroubi, S. A.; Brazier, J. E.; Roberts, J.; O'Hagan, A. (2007). Modelling SF-6D health state preference data using a nonparametric Bayesian method. Journal of Health Economics, 26(3), 597-612.
37. Polsky, D.; Glick, H. A.; Willke, R.; Schulman, K. (1997). Confidence intervals for cost-effectiveness ratios: A comparison of four methods. Health Economics, 6(3), 243-252.
38. Fenwick, E.; Marshall, D. A.; Levy, A. R.; Nichol, G. (2006). Using and interpreting cost-effectiveness acceptability curves: An example using data from a trial of management strategies for atrial fibrillation. Bmc Health Services Research, 6, 52.
39. Devlin, N.; Parkin, D. (2004). Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Economics, 13(5), 437-452.
40. George, B.; Harris, A.; Mitchell, A. (2001). Cost effectiveness analysis and the consistency of decision making - Evidence from pharmaceutical reimbursement in Australia (1991-1996). Pharmacoeconomics, 19(11), 1103-1109.
41. Bridges, J. F. P.; Onukwugha, E.; Mullins, C. D. (2010). Healthcare rationing by proxy cost-effectiveness analysis and the misuse of the $50 000 threshold in the US. Pharmacoeconomics, 28(3), 175-184.
42. Oluwatowoju, I.; Abu, E.; Wild, S. H.; Byrne, C. D. (2010). Improvements in glycaemic control and cholesterol concentrations associated with the quality and outcomes framework: A regional 2-year audit of diabetes care in the UK. Diabetic Medicine, 27(3), 354-359.
43. Holman, R. R.; Paul, S. K.; Bethel, M. A.; Matthews, D. R.; Neil, H. A. W. (2008). 10-year follow-up of intensive glucose control in type 2 diabetes. New England Journal of Medicine, 359(15), 1577-1589.
44. Curtin, K.; Beckman, H.; Pankow, G.; Milillo, Y.; Green, R. A. (2006). Return on investment in pay for performance: A diabetes case study. Journal of Healthcare Management, 51(6), 365-374.
45. Chen, T. T.; Chung, K. P.; Lin, I. C.; Lai, M. S. (2011). The unintended consequence of diabetes mellitus pay-for-performance (P4P) program in Taiwan: Are patients with more comorbidities or more severe conditions likely to be excluded from the P4P program? Health Services Research, 46(1 Pt 1), 47-60.
46. Solli, O.; Stavem, K.; Kristiansen, I. S. (2010). Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health and Quality of Life Outcomes, 8(18), 1-8.
47. Winkelmayer, W. C.; Kurth, T. (2004). Propensity scores: Help or hype? Nephrology, Dialysis, Transplantation, 19(7), 1671-1673.